Floatz logo

Namenda

Bipolar Disorder II

National Cheng-Kung University HospitalPhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

22 Active assets in the Bipolar Disorder II cohort.

Asset / SponsorPhaseRating
Lurasidone
Massachusetts General Hospital
Phase 4BBB
Valproic Acid
National Cheng-Kung University Hospital
Phase 4BB
Seroquel®
First Affiliated Hospital of Zhejiang University
Phase 4BB
VENLOR
Stanley Medical Research Institute
Phase 4BB
LITHIUM, ELEMENTAL
Brigham and Women's Hospital
Phase 4BB

View all 37 →

Same molecule, other indications

Namenda is also rated in:

Alzheimer diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
Lewy body dementiaDormant
BBB
Indicative ·
72 / 100
View asset →
dementiaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →